Abstract: In the present invention, there is provided a camouflage material having a camouflage pattern applied thereto and comprising a granitic aspect made of intermixed colored grains exhibiting the colors: light green having a dominant wavelength of 566.70 nm; a luminance factor of 13.10% and a saturation factor of 44.70%; brown having a dominant wavelength of 583.0 nm; a luminance factor of 9.30%, and a saturation factor of 31.60%; average green having a dominant wavelength of 569.36 nm; a luminance factor of 5.24%, and a saturation factor of 38.50%; and black having a dominant wavelength of 582.34 nm; a luminance factor of 2.68%, and a saturation factor of 4.01%. The granitic aspect is composed of about 21% colored grains exhibiting the color light green; about 6% colored grains exhibiting the color brown; about 48% colored grains exhibiting the color average green, and about 25% colored grains exhibiting the color black.

Abstract: A method for the treatment of symptoms related to normal hormonal variations in women during fertile, peri- and post-menopausal age, by the administering of a composition comprising, as active ingredients, a water and/or fat-soluble cytosolic extract of pollen, optionally combined with Royal Jelly and Vitamin E.

Abstract: A formulation having a rose hip concentrate is used to treat and/or alleviate the symptoms associated with inflammation including arthritis or to prevent development of arthritis. The rose hip concentrate has a high vitamin content relative to conventionally dried material, and is shown, in vitro, to inhibit the chemotaxis and oxidative burst response of human peripheral blood inflammatory cells, as well as the chemotaxis of monocytes. The formulation, in vivo, was found to inhibit chemotaxis of human peripheral blood inflammatory cells and to reduce the level of C-reactive protein, to alleviate pain and reduce inflammation in patients with arthritis.